Emerging risks | Growth Opportunities | APAC Insurance

Saturday, November 7, 2026

Non-life, Professional Indemnity, Ratings, Ratings affirmation

NZ Medical Indemnity’s ratings upheld as strategic shift boosts performance

AM Best affirms ratings, though disestablishment of district health boards could cause challenges.

By

Editorial team

May 3, 2024

•

3 min read

(Re)in AsiaSIRC 2026 Hub

(Re)in AsiaSIRC 2026HubExplore the hub →

Unlock this insight for free

Register for a free 14-day trial to read the full insight.

14 days of access to (Re)in Asia’s premium intelligence
Free daily briefing in your inbox each morning
No credit card required

Already have an account? Sign in →

(Re)in AsiaSIRC 2026 Hub

(Re)in AsiaSIRC 2026HubExplore the hub →

Read next

Motor and medical losses push Macau Insurance to underwriting loss in 2025 as AM Best affirms ratings September 2 2026
Rate changes, portfolio restructure improve Lippo General's 2025 performance as AM Best affirms ratings August 24 2026
DUAL expands title and legal indemnity capacity, geographic reach with international binder October 21 2026
South Korea’s FSS urges insurers to shift executive KPIs beyond short-term profit September 11 2026
Haze adds to medical claims pressure as Malaysian insurers face repricing constraints October 14 2026
APAC medical cost growth to slow to 9.7% in 2027, Aon forecasts October 8 2026